Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2010
12/21/2010US7854930 Anti-igf-ir antibodies and uses thereof
12/21/2010CA2591790C Genes coding for flavone synthases
12/21/2010CA2420771C Enhanced transfection system
12/21/2010CA2341636C Fusion proteins, dna molecules, vectors, and host cells useful for measuring protease activity
12/21/2010CA2329138C Glycoproteins having lipid mobilising properties and therapeutic applications thereof
12/21/2010CA2307316C Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies
12/21/2010CA2267069C Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
12/21/2010CA2220753C Novel peptides and compositions which modulate apoptosis
12/21/2010CA2161351C Transgenic non-human animals capable of producing heterologous antibodies
12/16/2010WO2010144712A1 Derivatives, reagents, and immunoassay for detecting levetiracetam
12/16/2010WO2010143698A1 Process for production of protein
12/16/2010WO2010142041A1 Serine rich peptides having antioxidative stress properties
12/16/2010WO2010107303A3 Chrysosporium lucknowense protein production system
12/16/2010US20100319090 Methods for producing secreted proteins
12/16/2010US20100317835 Anti-Adam-15 Antibodies and Utilization of the Same
12/16/2010US20100317599 Process for the production of a peptide
12/16/2010US20100317596 Serum amyloid p derivatives and their preparation and use
12/16/2010US20100317546 Display Vectors and Methods and Uses Thereof
12/16/2010US20100317540 Methods for producing members of specific binding pairs
12/16/2010US20100317096 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
12/16/2010US20100317057 Semi-recombinant preparation of glp-1 analogues
12/16/2010US20100317056 Fermentation medias and processes thereof
12/16/2010US20100317055 Recombinant Cell Clones Having Increased Stability and Methods of Making and Using the Same
12/16/2010US20100317054 PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF
12/16/2010US20100317046 Non-Endogenous, Constitutively Activated Versions of Human G Protein Coupled Receptor: FSHR
12/16/2010US20100317026 VMP-Like Sequences Of Pathogenic Borrelia
12/16/2010US20100316703 Rna interference mediating small rna molecules
12/16/2010US20100316645 Bispecific Antigen Binding Proteins
12/16/2010US20100316634 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
12/16/2010US20100316563 Method For The Preparation Of New Oligoclonal Antibodies
12/16/2010CA2768246A1 Serine rich peptides having antioxidative stress properties
12/16/2010CA2765242A1 Process for production of protein
12/15/2010EP2261358A2 Novel streptococcus antigen
12/15/2010EP2261357A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261356A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261355A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261354A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261353A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261352A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261351A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261350A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261349A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261348A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261347A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261346A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261345A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261344A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261343A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261342A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261341A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261340A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261339A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261338A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261335A1 Compositions and methods for increasing bone mineralisation
12/15/2010EP2261330A1 Factor VII Glycoforms
12/15/2010EP2261317A1 Microorganism producing cyclic compound
12/15/2010EP2261250A1 Albumin fusion proteins
12/15/2010EP2261241A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/15/2010EP2261238A1 Cyclic compound and salt thereof
12/15/2010EP2261237A2 Daptomycin and related analogs in crystalline form, their preparation and use
12/15/2010EP2261229A2 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
12/15/2010EP2260863A1 Prophylactic/therapeutic agent for infectious disease
12/15/2010EP2260106A1 Improved beta thymosin fragments
12/15/2010EP1799838B1 Methods of producing bioactive compositions
12/15/2010EP1678297B1 Method for producing gamma-carboxylated proteins
12/15/2010EP1525313B1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase
12/15/2010EP1123977B1 GENES ENCODING PROTEINS REGULATING pH OF VACUOLES
12/15/2010EP1076703B2 Therapeutic uses of il-17 homologous polypeptides
12/15/2010CN1824292B Medicine for improving brain function its preparation method and use
12/15/2010CN101918579A Fully human anti-VEGF antibodies and methods of using
12/15/2010CN101918578A Promoter detection and analysis
12/15/2010CN101918559A Modifying glycoprotein production in plants
12/15/2010CN101918555A Humanized anti-alpha9 integrin antibodies and the uses thereof
12/15/2010CN101918549A Improved humanized anti-human alpha9-integrin antibody
12/15/2010CN101918452A Monoclonal antibody capable of binding to Anexelekto, and use thereof
12/15/2010CN101918450A Anti-CLDN6 antibody
12/15/2010CN101917866A Protein hydrolysate compositions having improved sensory characteristics and physical properties
12/15/2010CN101914604A Antioxidant peptide active protection in protein enzymolysis process and preparation method thereof
12/15/2010CN101914603A Fermentation method for production of recombination protein by lactose-induced pMFH carrier
12/15/2010CN101914549A Transcription factor gene induced by dehydration condition and abscisic acid in sunflower, promoter and transgenic plant
12/15/2010CN101914143A HIV-1 membrane fusion inhibitor and application thereof
12/15/2010CN101914043A Method for synchronously extracting and preparing taurine, biological zinc and polypeptide from oysters
12/15/2010CN101913583A Method for extracting chondroitin, collagen and high-calcium powder from animal cartilage
12/14/2010US7851608 Expression vector comprising nucleotide sequences which code plant regulatory sequences; for use in controlling root length, senecense and/or water and nutrient uptake
12/14/2010US7851607 Expression vector comprising nucleotide sequences coding porcine reproductive and respiratory syndrome polypeptide for use in generating vaccine to prevent viral infection; immunotherapy
12/14/2010US7851601 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
12/14/2010US7851599 Combination of an anti-ED—B fibronectin domain antibody—IL-2 fusion protein and gemcitabine
12/14/2010US7851594 Human cytokine receptor
12/14/2010US7851437 monoclonal antibody conjugated with peptide drug such as dolastatin derivative
12/14/2010US7851199 Production of carotenoids in oleaginous yeast and fungi
12/14/2010US7851197 Exoenzyme toxin of Aeromonas salmonicida, and uses therefor
12/14/2010US7851193 Polypeptides having xylanase activity and polynucleotides encoding same
12/14/2010US7851192 having at least 35% amino acid sequence identity with T7 Endo I, two catalytic centers separated by a beta -bridge, and a mutation of at least one amino acid in the beta -bridge that has an effect of altering cleavage activity; reduced toxicity in a host cell permitting over-expression of the enzyme
12/14/2010US7851191 Product and process for transformation of thraustochytriales microorganisms
12/14/2010US7851188 producing isobutanol by the fermentive growth of a recombinant bacteria expressing a isobutanol biosynthetic pathway
12/14/2010US7851181 Generating monoclonal antibodies specific to insulin-like growth factor receptor-I (IGFR1) for use in treatment and prevention of cell proliferative disorders
12/14/2010US7851171 Using actinobacillus specific immunogolbulins to diagnose gum disease
12/14/2010US7851170 Modified cell for production of grampositive specific immunoglobulins
12/14/2010US7850980 Chlamydia OMP antigen
12/14/2010US7850974 Using sequences infomation to identify microbial surface components recognizing adhesive matrix molecules (MSCRAMM proteins) in order to diagnose, treat and prevent bacterial infection
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 1125